Double-blind, Randomised Study of A3384 in BAM/BAD
NCT02078856
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
19
Enrollment
INDUSTRY
Sponsor class
Conditions
Bile Acid Malabsorption
Interventions
DRUG:
A3384
Sponsor
Albireo